研究表明，SL-NAD+ 舌下晶片具有 22% 的生物利用度，绕过消化系统并提高细胞 NAD+ 水平。 Study shows SL-NAD+ sublingual wafer has 22% bioavailability, bypassing digestive system and enhancing cellular NAD+ levels.
iX Biopharma 的一项研究表明，SL-NAD+ 是一种舌下含服 NAD+ 晶片，可有效地将 NAD+ 直接输送到细胞中，与静脉注射方法相比，生物利用度为 22%。 A study by iX Biopharma reveals that SL-NAD+, a sublingual NAD+ wafer, effectively delivers NAD+ directly into cells, demonstrating a 22% bioavailability compared to intravenous methods. 这种创新办法绕过消化系统,提高了细胞型NAD+水平,并有可能提供更方便的替代四类治疗的办法。 This innovative approach bypasses the digestive system, enhancing cellular NAD+ levels and potentially offering a more convenient alternative to IV therapy. NAD+对于能源生产、新陈代谢、DNA修复和健康老龄化至关重要,使这一发展对于与年龄有关的健康管理具有重大意义。 NAD+ is crucial for energy production, metabolism, DNA repair, and healthy aging, making this development significant for age-related health management.